Literature DB >> 31612821

Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance.

Adeeb Shehzad1, Vijaya Ravinayagam2, Hamad AlRumaih3, Meneerah Aljafary4, Dana Almohazey5, Sarah Almofty5, Noor A Al-Rashid1, Ebtesam A Al-Suhaimi4,5.   

Abstract

The in-vitro experimental model for the development of cancer therapeutics has always been challenging. Recently, the scientific revolution has improved cell culturing techniques by applying three dimensional (3D) culture system, which provides a similar physiologically relevant in-vivo model for studying various diseases including cancer. In particular, cancer cells exhibiting in-vivo behavior in a model of 3D cell culture is a more accurate cell culture model to test the effectiveness of anticancer drugs or characterization of cancer cells in comparison with two dimensional (2D) monolayer. This study underpins various factors that cause resistance to anticancer drugs in forms of spheroids in 3D in-vitro cell culture and also outlines key challenges and possible solutions for the future development of these systems. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  2D monolayer; 3D cell culture; cancer therapy; drug discovery; drug resistance.; spheroid

Mesh:

Substances:

Year:  2019        PMID: 31612821     DOI: 10.2174/1381612825666191014163923

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

Review 1.  Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy.

Authors:  Aroosa Younis Nadeem; Adeeb Shehzad; Salman Ul Islam; Ebtesam A Al-Suhaimi; Young Sup Lee
Journal:  Vaccines (Basel)       Date:  2022-04-30

Review 2.  A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer.

Authors:  Li Liu; Lu Yan; Ning Liao; Wan-Qin Wu; Jun-Ling Shi
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

Review 3.  Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.

Authors:  Bárbara Pinto; Ana C Henriques; Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2020-12-06       Impact factor: 6.321

4.  KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model.

Authors:  Susumu Ohya; Junko Kajikuri; Kyoko Endo; Hiroaki Kito; Miki Matsui
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.